Will Semaglutide Show Up in Your Bloodwork?

Does semaglutide appear on standard blood tests?

No. The blood tests most people encounter (ordered by a GP, occupational health team, or private health check) look for specific cellular counts, enzymes, hormones and metabolites that the lab is configured to measure. Semaglutide is not on that list. A full blood count measures your red and white cells and platelets. A metabolic panel checks kidney function, electrolytes and liver enzymes. A lipid screen reports your cholesterol fractions. None of these panels include a semaglutide assay.

To detect semaglutide in blood, a laboratory would need to run a targeted immunoassay, a specialised test calibrated specifically to bind to semaglutide peptides. These assays exist in pharmaceutical research settings and were used during the clinical trials to measure drug concentrations precisely. They are not part of any routine NHS, occupational health or insurance screening panel in the UK. If you want a deeper look at whether semaglutide will show up in a blood test, we cover the science behind those assays and what routine panels actually measure. So if your concern is privacy around a workplace health assessment or a GP's routine annual check, you can be reassured: your bloodwork will not flag the medicine.

You can read more about how semaglutide works as a treatment on our semaglutide overview, which covers the mechanism, the evidence and the licensed uses in the UK.

What changes in bloodwork are common once treatment starts?

This is where things get genuinely interesting, and it is a question our prescribers hear fairly regularly. While semaglutide itself stays invisible to standard panels, its effects on your metabolism often do not. Several measurable markers tend to shift as weight falls and appetite reduces.

HbA1c (the three-month average of blood glucose) commonly falls, sometimes substantially, in people who had prediabetes or type 2 diabetes at the start of treatment. Triglycerides, a fat fraction in your lipid panel, often reduce as caloric intake decreases. Liver enzymes such as ALT and AST can improve in people with raised levels linked to fatty liver disease. Blood pressure, though not a blood test, tracks downward for many people too. The NHS medicines page for semaglutide gives a clear patient-level summary of how the medicine works and what to expect.

None of these shifts are guaranteed, and they depend on your starting point, the dose reached and lifestyle factors alongside treatment. But it is worth knowing that bloodwork taken six months into treatment can look noticeably different from the baseline, and in ways your GP will want to know about. Tell your GP you are on semaglutide so they can interpret any results in context. That conversation matters.

Will semaglutide show up in a drug test or occupational screen?

Standard workplace drug tests screen for a defined panel: typically cannabis, opioids, amphetamines, cocaine and benzodiazepines. Semaglutide is a peptide hormone, structurally unrelated to any of those substances. It does not cross-react with standard immunoassay drug screens and would not cause a false positive for any controlled substance. If you have seen questions elsewhere about whether semaglutide shows on a drug test, the answer is the same: no standard occupational or forensic panel tests for it.

One practical note: some people worry that being on a GLP-1 medicine could somehow affect their test. It will not. The only scenario in which semaglutide concentration in blood is ever measured is in a research or pharmacokinetic context, and even then, only using bespoke assays arranged for that specific purpose. If you work in a safety-critical role and have any doubt, speaking to your occupational health physician is sensible, but the concern about a standard drug screen detecting Wegovy is not one that holds up clinically. A related question we often hear is whether Wegovy actually melts fat, and the answer involves a more nuanced look at how the medicine produces its effects on body composition.

Should you tell your GP or other doctors you are taking semaglutide?

Yes, straightforwardly and without hesitation. This is not about bloodwork detection; it is about good clinical care. Semaglutide slows gastric emptying, which can affect how quickly other oral medicines are absorbed. If your GP is adjusting your blood pressure medication, reviewing your diabetes management or planning any procedure, they need the full picture. The NHS England guidance on weight-management injections specifically advises telling your surgical team and anaesthetist before any procedure.

If you started treatment through a private route, good practice is to ensure your GP knows. At nume at our pharmacy, GP notification is part of the standard process in line with GPhC guidance. A prescriber reviews every consultation personally before any medicine is dispensed, and the process includes keeping your wider care team appropriately informed. That is a safety standard, not a formality.

Thinking about treatment and want to talk it through? Take a look at our Wegovy page for the full picture on what is involved, or review the weight-loss treatment options we offer. If you are also thinking about what private treatment costs, our Wegovy pricing page explains how the price is structured and what is included. When you are ready, start your free consultation and a GPhC-registered prescriber will review your case the same day.